Biomatics Capital is a venture capital firm that focuses on investing in transformational innovation at the intersection of healthcare and technology. Their strategy involves early-stage investments, primarily in genomics, digital health, and data-driven healthcare technologies, often taking a lead role in Series A funding rounds.
67% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (67% of deals). Average disclosed round size is $51.7M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$200M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Encodia | Series C | $75M | Jan 2021 |
 Omniome, Inc. | Series C | $60M | Jan 2020 |
 Aledade | Series B | $20M | Jan 2017 |
Top Co-Investors
ARCH Venture Partners3 shared
Nan Fung Life Sciences2 shared
GV (Google Ventures)2 shared
Domain Associates1 shared
Altitude Life Science Ventures1 shared
Northpond Ventures1 shared
Deerfield1 shared
Alexandria Venture Investments1 shared
Tao Capital Partners1 shared
Maryland Venture Fund1 shared
Venrock1 shared
Last updated: 28 April 2026